PNPLA3 and hepatocellular carcinoma: The HCC incidence rates were significantly lower in women, people aged < 60 years, subjects with normal ALT levels, and those carrying non-risk genotypes of PNPLA3 rs738409 and TM6SF2 rs58542926 than in their respective counterparts, although the age of HCC diagnoses was comparable.